Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763687 | PMC |
http://dx.doi.org/10.4103/0019-5154.174194 | DOI Listing |
Rheumatology (Oxford)
January 2025
Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Objectives: To evaluate the prevalence and clinical associations of anti-C1q antibodies in IgG4-related disease (IgG4-RD), focusing on renal involvement and cutaneous small-vessel vasculitis (CSVV).
Methods: We enrolled patients who met the revised 2020 Comprehensive Diagnostic Criteria and/or the 2019 ACR/EULAR Classification Criteria for IgG4-RD. Variables included demographics, organ involvement, clinical phenotypes, disease activity, serum biomarkers, follow-up duration, remission, and relapses.
Cureus
July 2024
Otolaryngology, Head and Neck Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, JPN.
Objective: Immunoglobulin G4-related disease (IgG4-RD) is a systemic inflammatory condition affecting multiple organs, including the pancreas, salivary glands, lungs, kidneys, skin, and lymph nodes. Clinically, it is characterized by elevated serum IgG and IgG4 levels and tissue infiltration by IgG4-positive plasma cells, lymphocytes, fibrosis, and phlebitis obliterans. IgG4-RD is linked to increased Th2-dominant cytokines, contributing to eosinophilia, elevated serum IgG4, and fibrosis.
View Article and Find Full Text PDFEur J Dermatol
August 2024
Department of Dermatology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
J Cutan Pathol
November 2024
Dermatology Department, Virgen del Rocío University Hospital, Seville, Spain.
Neuropathology
December 2024
Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!